المؤلفون: Poot CC, de Boer J, Goto L, van de Hei SJ, Chavannes NH, Visch VT, Meijer E

المصدر: Patient Preference and Adherence, Vol Volume 17, Pp 2719-2736 (2023)

مصطلحات موضوعية: medication adherence, serious game design, behavior change, adherence monitoring, participatory design, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/the-design-of-a-persuasive-game-to-motivate-people-with-asthma-in-adhe-peer-reviewed-fulltext-article-PPA; https://doaj.org/toc/1177-889X

URL الوصول: https://doaj.org/article/82478c4ce9d94336a7a407bb818d0041

المؤلفون: Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Primary and Long-term Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Eikholt AA; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., van de Hei SJ; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Muris JWM; Department of General Practice, Research Institute CAPHRI, Maastricht University, Maastricht, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases and Tuberculosis, University of Groningen University Medical Center Groningen, Groningen, The Netherlands., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

المصدر: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

المؤلفون: Achterbosch M; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands., van de Hei SJ; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, The Netherlands., Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, The Netherlands.; Observational and Pragmatic Research Institute, Singapore, Singapore.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van den Berge M; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, The Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, The Netherlands., van Dijk L; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands.; Nivel, Utrecht, The Netherlands.; Department of PharmacoTherapy, -Epidemiology & -Economics (PTEE), Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.

المصدر: NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2024 May 28; Vol. 34 (1), pp. 13. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Feasibility Studies* , Medication Adherence*/statistics & numerical data , Pulmonary Disease, Chronic Obstructive*/drug therapy , Asthma*/drug therapy , Nebulizers and Vaporizers*, Humans ; Male ; Female ; Middle Aged ; Administration, Inhalation ; Aged ; Adult

المؤلفون: Dierick BJH; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of General Practice & Elderly Care Medicine, Groningen, the Netherlands., Achterbosch M; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands., Eikholt AA; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., van de Hei SJ; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands., Hagedoorn P; University of Groningen, Groningen Research Institute of Pharmacy, Department of Pharmaceutical Technology and Biopharmacy, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Kerstjens HAM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Groningen, the Netherlands., Kocks JWH; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands; Observational and Pragmatic Research Institute, Singapore., van Boven JFM; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands. Electronic address: j.f.m.van.boven@umcg.nl.

المصدر: Respiratory medicine [Respir Med] 2023 Nov; Vol. 218, pp. 107376. Date of Electronic Publication: 2023 Aug 06.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy, Adult ; Humans ; Nebulizers and Vaporizers ; Administration, Inhalation ; Metered Dose Inhalers ; Medication Adherence ; Electronics

المؤلفون: van de Hei SJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands., Kim CH; Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver, Colo., Honkoop PJ; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Sont JK; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Schermer TRJ; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands; Science Support Office, Gelre Hospitals, Apeldoorn, the Netherlands., MacHale E; Clinical Research Centre, Smurfit Building Beaumont Hospital, Department of Respiratory Medicine, RCSI, Dublin, Ireland., Costello RW; Clinical Research Centre, Smurfit Building Beaumont Hospital, Department of Respiratory Medicine, RCSI, Dublin, Ireland., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Center of Excellence for Pharmaceutical Care Innovation, Padjadjaran University, Bandung, Indonesia; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, The Netherlands., van Boven JFM; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2023 Oct; Vol. 11 (10), pp. 3064-3073.e15. Date of Electronic Publication: 2023 Jul 03.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Biosimilar Pharmaceuticals*/therapeutic use , Asthma*/drug therapy, Humans ; Cost-Benefit Analysis ; Nebulizers and Vaporizers ; Administration, Inhalation ; Medication Adherence

المؤلفون: van de Hei SJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, the Netherlands., Stoker N; General Practitioners Research Institute, Groningen, the Netherlands., Flokstra-de Blok BMJ; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, the Netherlands.; Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Poot CC; Department of Primary Care and Public Health, Leiden University Medical Center, Leiden, The Netherlands.; National eHealth Living Lab, Leiden, The Netherlands., Meijer E; Department of Primary Care and Public Health, Leiden University Medical Center, Leiden, The Netherlands.; National eHealth Living Lab, Leiden, The Netherlands., Postma MJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Chavannes NH; Department of Primary Care and Public Health, Leiden University Medical Center, Leiden, The Netherlands.; National eHealth Living Lab, Leiden, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, the Netherlands.; Observational and Pragmatic Research Institute, Singapore, Singapore.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands., van Boven JFM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia. j.f.m.van.boven@umcg.nl.

المصدر: NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2023 May 20; Vol. 33 (1), pp. 22. Date of Electronic Publication: 2023 May 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy, Humans ; Female ; Nebulizers and Vaporizers ; Medication Adherence ; Health Personnel ; Focus Groups ; Qualitative Research

المؤلفون: van de Hei SJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands s.j.van.de.hei@umcg.nl.; General Practitioners Research Institute, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Poot CC; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands., van den Berg LN; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands., Meijer E; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands., van Boven JFM; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands., Flokstra-de Blok BMJ; General Practitioners Research Institute, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Chavannes NH; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands., Kocks JWH; General Practitioners Research Institute, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands.; Observational and Pragmatic Research Institute, Singapore.

المصدر: BMJ open respiratory research [BMJ Open Respir Res] 2022 Dec; Vol. 9 (1).

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Print Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/diagnosis , Mobile Applications*, Adult ; Humans ; Quality of Life ; Nebulizers and Vaporizers ; Medication Adherence ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

المؤلفون: Dierick BJH; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of General Practice & Elderly Care Medicine, Groningen, the Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Hagedoorn P; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., van de Hei SJ; University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands., Kerstjens HAM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Pulmonology and Tuberculosis, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Kocks JWH; General Practitioners Research Institute, Groningen, the Netherlands; Observational and Pragmatic Research Institute, Singapore; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Zijp TR; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Wessels AMA; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Touw DJ; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., van Boven JFM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands. Electronic address: j.f.m.van.boven@rug.nl.

المصدر: Respiratory medicine [Respir Med] 2022 Sep; Vol. 201, pp. 106940. Date of Electronic Publication: 2022 Jul 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Bronchodilator Agents*/therapeutic use , Pulmonary Disease, Chronic Obstructive*/drug therapy, Administration, Inhalation ; Formoterol Fumarate/therapeutic use ; Humans ; Metered Dose Inhalers ; Nebulizers and Vaporizers

المؤلفون: Dierick BHJ; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of General Practice & Elderly Care Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Achterbosch M; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Been-Buck S; Department of Pulmonology, Martini Hospital, Groningen, The Netherlands., Klemmeier T; Department of Pulmonology, Martini Hospital, Groningen, The Netherlands., van de Hei SJ; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hagedoorn P; Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kocks JWH; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.; Observational and Pragmatic Research Institute, Singapore.; General Practitioners Research Institute, Groningen, The Netherlands., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands j.f.m.van.boven@umcg.nl.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.

المصدر: BMJ open [BMJ Open] 2022 Jun 13; Vol. 12 (6), pp. e059929. Date of Electronic Publication: 2022 Jun 13.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Bronchodilator Agents*, Administration, Inhalation ; Electronics ; Humans ; Medication Adherence ; Multicenter Studies as Topic ; Nebulizers and Vaporizers ; Randomized Controlled Trials as Topic

المؤلفون: van de Hei SJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands., Dierick BJH; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of General Practice and Elderly Care Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Aarts JEP; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore., van Boven JFM; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia; Medication Adherence Expertise Center of the northern Netherlands, Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Nov; Vol. 9 (11), pp. 3979-3994. Date of Electronic Publication: 2021 Jun 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Pulmonary Disease, Chronic Obstructive*/drug therapy, Adult ; Humans ; Medication Adherence ; Nebulizers and Vaporizers